Accretion/Dilution Analysis

The M&A arithmetic that determines whether a deal makes sense for the acquirer. If post-merger EPS rises, the deal is accretive. If it falls, it's dilutive. Fully worked example included.

What Accretion/Dilution Means

When a public company acquires another, analysts immediately ask: what happens to earnings per share? The answer drives stock price reaction on announcement day and shapes how the CEO frames the deal to shareholders.

• Accretive: Post-merger EPS > Pre-merger EPS — the deal added more earnings than it cost in shares issued or interest on acquisition debt.
• Dilutive: Post-merger EPS < Pre-merger EPS — the deal destroyed EPS, at least initially.
• Neutral (breakeven): Post-merger EPS = Pre-merger EPS — rare in practice; usually a deliberate target for structuring.

Why does this matter? Public company CEOs are under constant pressure to show EPS growth. A dilutive deal — even one that makes strategic sense — gets punished by the market if management cannot articulate a credible path to accretion. Investment bankers spend significant time structuring deals (mix of stock vs. cash, synergy targets, deal timing) specifically to hit an accretion/dilution profile the acquirer's board will approve.

The Setup — Deal Parameters

We will build a complete accretion/dilution model for a 100% stock deal. All-stock deals are the cleanest way to learn the mechanics because there is no interest expense to model — just share count math.

The exchange ratio tells target shareholders how many acquirer shares they receive per target share. At $40 acquirer stock and a $32.50 offer price, each target share converts to 0.8125 acquirer shares. With 100M target shares outstanding, the acquirer must print 81.25M new shares.

Step 1 — Pro Forma Shares Outstanding

Start with the acquirer's diluted share count and add the new shares issued as deal consideration.

Note: in a real model you would also add any in-the-money target options that get cashed out or converted, and any dilutive securities of the combined company. For this walkthrough we keep it clean.

Step 2 — Pro Forma Net Income

Combine the two companies' net incomes, add after-tax synergies, and subtract any new costs created by the transaction.

Under US GAAP (ASC 350), goodwill from an acquisition is NOT amortized — it stays on the balance sheet and is tested annually for impairment. This is different from IFRS, which allows amortization in some jurisdictions. Interviewers sometimes test this distinction.

Step 3 — Pro Forma EPS and the Verdict

The deal is 11.1% dilutive. Even with $50M of synergies, the acquirer destroyed EPS by buying a more expensive stock (25x P/E) with its own cheaper stock (13.3x P/E). Share count grew 40.6% while earnings only grew 25.0% — the math never works when you buy high-multiple assets with low-multiple currency.

Why It's Dilutive — The P/E Relationship

This is the conceptual insight interviewers want to hear. You don't need to run the full model to know directionally whether a stock deal will be accretive or dilutive — you just need to compare P/E multiples.

Here is the intuition. In a stock deal, the acquirer is spending its own earnings (priced at 13.3x) to buy the target's earnings (priced at 25.0x). Every dollar of target earnings costs $25 in deal currency, but only "returns" $13.30 in acquirer market cap. The spread destroys EPS. Synergies can overcome this — but need to be substantial.

What If the Acquirer Were the Higher-Multiple Stock?

Flip the scenario: acquirer at 25x P/E, target at 13.3x P/E. Now the acquirer is spending expensive stock to buy cheap earnings. Each target dollar of earnings costs $13.30 but gets repriced at 25x in the combined entity. That spread creates accretion. High-multiple acquirers (like fast-growing tech companies) have a structural advantage in stock-for-stock M&A.

Synergies Required for Breakeven

A common interview ask: "How much in synergies does this deal need to be EPS-neutral?" Solve backwards from the target EPS.

The breakeven synergy requirement of $191.7M pre-tax is substantial — roughly equivalent to eliminating the entire target's cost base. This is a useful sanity check: if the required synergies seem unrealistic, the deal probably shouldn't be done at that valuation.

Cash vs. Stock Deal Comparison

Now run the same acquisition as a 100% cash deal financed entirely with new debt at 6% interest. The mechanics change: instead of share dilution, you have an interest expense drag.

The cash deal is marginally accretive despite the massive debt load. Why? Because the interest tax shield and no share dilution tip the math in favor of cash when the acquirer's P/E is much lower than the target's. This demonstrates a general principle: when the acquirer's P/E is low, cash deals tend to be more accretive than stock deals.

Five Common Interview Questions